Zynex ( ($ZYXI) ) has shared an update. On December 15, 2025, Zynex, Inc. filed for Chapter 11 bankruptcy in the Southern District of Texas, ...

Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive ...

The company voluntarily filed for Chapter 11 and entered into a restructuring agreement with its lenders.

SAN FRANCISCO, March 28, 2025 (GLOBE NEWSWIRE) -- A securities class action has been filed against Zynex, Inc. (NASDAQ: ZYXI), a medical device manufacturer that produces and markets electrotherapy ...

Zynex has announced it received FDA clearance for a new device used primarily for treating female urinary incontinence, according to a news release. The InWave medical device will be manufactured, ...

Zynex, a medical device manufacturer, has reported a 36% year-over-year increase in revenue in Q1 2023, reaching $42.2 million, with a 14% increase in net income. Despite short-term underperformance, ...

ENGLEWOOD, Colo., Feb. 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

Shares of Zynex (NASDAQ: ZYXI) are up more than 9% early Wednesday afternoon after the medical equipment company announced it planned to do a stock repurchase. That said, the stock is down more than ...

LONE TREE, Colo.--(BUSINESS WIRE)--Zynex, Inc. (OTCBB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac ...

Zynek makes electrotherapy devices to control pain. The company grew revenue and net income in the first quarter. However, the stock is still down more than 32% so far this year. After buying back $30 ...